NFKB1 and cancer: Using autophagy inhibitors (chloroquine and 3-methyladenine), it was shown that treatment suppressed the phosphorylation and consequent degradation of NF-κB inhibitor (I-κBα), which prevented the resistance of cancer cells to chemotherapeutic agents [119].